Nurses throughout history, including myself, have had a calling to perform the special work that we perform. Hospitals have increasingly been staffing with bare-bones staffing. Too frequent within our profession is the normalization of unsafe conditions supported by administration. Patients are in the hospital setting because they are too sic
The health care system had 16,871 employees as of Sept. 5, the date in which it completed its acquisition of High Point Regional Health System with its workforce of 2,600 and 351 licensed beds. Wake Forest Baptist said in a statement the eliminated positions "were across its system." The job cuts are the first made public by Wake Forest Baptist sin
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today announced that it has enrolled the first subject in a Phase 2 b clinical trial of BPX-04, a novel topical gel formulation of minocycline for the treatment of rosacea. The 12- week, multi-center study will evaluate BPX-04, a 1% topical min
Bridge Biotherapeutics said Friday that it has completed phase-1 clinical trials for BBT-401, an investigational drug for ulcerative colitis, in the U.S.. BBT-401 is a first-in-class candidate jointly developed by Korea Research Institute of Chemical Technology and Professor Park Seok-hees team at Sungkyunkwan University. The company conducted the.
Los Angeles, CA 10/13/2018 This report focuses on the global Clinical Trial Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trial Management development in United States, Europe and China. In 2017, the global Clinical Trial Management market size was 630 mill
LONDON, 12 October 2018/ PRNewswire Policy/ CVMP initiates two referral procedures to harmonise consumer safety aspects of veterinary medicines containing paromomycin and tylosin, respectively. The European Medicines Agency' s Committee for Medicinal Products for Veterinary Use adopted a negative opinion for an initial marketing authorisation...
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced a one-hour webinar focused on its ongoing US Phase I clinical trial on Niemann-Pick Disease Type C using Trappsol Cyclo via an intravenous administration route. N. Scott Fine, CTD Holdings Chairman and C
Deep Lens Inc., a digital pathology startup combining artificial intelligence and advanced cloud-based, pathology workflows to improve efficiency and enable patient access to cancer clinical trials, today announced the appointment of three new executives and a top-tier advisory board. Our ambitious mission to support and empower pathologists around
New York, NY 10/12/2018 A new market assessment report on the global Dental Prosthetics Dental Consumables market report gathers data to help understand stakeholders and business owners about the business environment and external customers during the forecast period, 2018 to 2025. Global Dental Prosthetics Dental Consumables market competitio
New York, NY 10/13/2018 Diabetes Management Software Market: Overview. The robust healthcare industry in North America is expected to propel demand for diabetes management software across the region. Furthermore, the favorable reimbursement policies for patients suffering from chronic diseases such as diabetes, high blood pressure, and cardio
Arikayce, a new drug for treating lung disease caused by a group of bacteria, Mycobacterium avium complex, was recently approved by the FDA for treating a limited population of patients with the disease who do not respond to conventional treatment. That means utilizing novel tools intended to streamline development and encourage investment into the
The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell types. "The approval of the ID CORE XT Test can streamline blood compatibility testing and provides an a
The FDA has approved and tentatively approved more generic drugs in FY 2018 than any other year prior, the agency announced Thursday. When I started as FDA commissioner, I made clear that one of my top priorities would be ensuring the agency does all it can to help ensure American patients have access to affordable, quality medicines that meet thei
The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award up to five cooperative agreements for orphan products research. It was posted Oct. 12 with an application closing date of Jan. 10, 2019. TARGETED NEWS SERVICE: Myron Struck, editor; 703/ 304-1897; email@example.com; https://target
In order to stay fit and healthy, consumers all across the world are preferring to consume dietary supplements and avoid chronic disease conditions like high blood pressure, obesity and diabetes. Persistence Market Research presents a novel research report on the global general well-being dietary supplements market that includes an analysis and...
Pune, India 10/12/2018 Global IT Spending in Remote Healthcare Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. Top Key Vendors: InVentiv Health, Interpace BioPharma, LLC, United Drug Plc., Pharmexx UK. Increase in disposable income, large patient population, and government intervention to improve heal
New York, NY 10/13/2018 "Telehealth involves the distribution of health-related services and information via electronic information and telecommunication technologies. It allows long distance patient/clinician contact and care, advice, reminders, education, intervention, monitoring and remote admissions. " Global Telehealth Virtual Visits Mar
New York, NY 10/13/2018 Improvement in voice recognition technology especially in the field of natural language processing and various other cross-linking features are enhancing the performance of chatbots in healthcare application. Increasing reliance on cloud-based services due to the provision of large data storage space and application of
Contract notice: Improving the quality of follow-up care. Short description: The subject of delivery is the delivery of new endoscopic and surgical instruments for the Neurosurgical Clinic necessary for the installation, commissioning and trouble-free operation and provision of warranty and post-warranty service to the supplied system.
An Indian-American cardiologist and entrepreneur has invested $60 million in a medical company that will support clinical trial on cardiac devices to replace stent. Dr Kiran Patel`s investment is for the Concept Medical Inc, a Florida- based medical device company`s Investigational Device Exemption for the world`s first sirolimus-coated balloon.
Brooklyn, NY 10/12/2018 Qyresearchreports include new market research report Bio Pharma Logistics to its huge collection of research reports. This report studies the global Bio Pharma Logistics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Bio Pharma Logist
Harrisburg, NC 10/12/2018 Global MHealth Solutions Market Size, Status and Forecast 2025 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report researches the worldwide MHealth Solutions Market size in key regions like North America, Europe, Asia Pacific
Address: Head Quarters Office, Loco Colony, Jaipur -302006, Rajasthan, Attn: Divisional Railway Manager. Description: Tenders are invited for Miph Stapler, Size- 33 to 35 mm. Us- Fda Approved Tender Closing Date Time: 17/10/2018 16:00.
-MRI Interventions, Inc. and Monteris Medical, Inc. today announced a collaborative co-development agreement to provide a next-generation head fixation frame for use in laser ablation neurosurgery. Under terms of the agreement, Monteris will provide a license to intellectual property and technical development to MRI Interventions, who will in turn.
Alberto Martinez, President and CEO, Mundipharma International Ltd, said: Our biosimilars platform is a key component of our growth strategy and todays acquisition is the obvious next step in us ensuring we remain agile and innovative in the biosimilars space. Enrique Ordieres, President of Infarco the parent company of Cinfa Group, commented: Afte